C
Cláudia Marques
Researcher at University of Porto
Publications - 32
Citations - 620
Cláudia Marques is an academic researcher from University of Porto. The author has contributed to research in topics: Leishmania infantum & Immune system. The author has an hindex of 15, co-authored 31 publications receiving 524 citations. Previous affiliations of Cláudia Marques include Instituto Nacional de Saúde Dr. Ricardo Jorge & University of the Algarve.
Papers
More filters
Journal ArticleDOI
Sustained drug release by contact lenses for glaucoma treatment—A review
TL;DR: This paper elaborated a review of the various methods exploited so far to improve the contact lenses' characteristics as mechanisms for controlled and prolonged drug release for topical treatment of ocular diseases, with particular emphasis on the treatment of glaucoma.
Journal ArticleDOI
Identification of regulatory T cells during experimental Leishmania infantum infection.
Olivia Roos Rodrigues,Cláudia Marques,Marta Soares-Clemente,Maria Helena Ferronha,Gabriela Santos-Gomes +4 more
TL;DR: Findings suggest that distinct regulatory T cells develop in response to L. infantum and may play a possible role in promoting parasite persistence and the establishment of chronic infection.
Journal ArticleDOI
Cytokine gene expression in the tissues of dogs infected by Leishmania infantum.
Marco Antonio Barbosa,Graça Alexandre-Pires,M. Soares-Clemente,Cláudia Marques,O. Roos Rodrigues,T. Villa de Brito,I. Pereira da Fonseca,L.C. Alves,Gabriela Santos-Gomes +8 more
TL;DR: Evaluating the level of expression of genes encoding particular cytokines in different tissues and organs of 53 adult dogs with or without clinical signs of leishmaniosis and after treatment for the disease concluded that L. infantum appears able to regulate the host immune response in order to ensure its survival, but also to prevent the host from succumbing to infection.
Journal ArticleDOI
Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response
TL;DR: A role of these proteins fractions in the modulation of host immunity, that depending on the host genetic background and parasite magnitude, seem to be critical in the control of parasite replication levels, thus avoiding premature host death is pointed out.
Journal ArticleDOI
A Plasmodium berghei sporozoite-based vaccination platform against human malaria.
António M. Mendes,Marta Machado,Nataniel Goncalves-Rosa,Isaie J. Reuling,Lander Foquet,Cláudia Marques,Ahmed M. Salman,Ahmed M. Salman,Annie S. P. Yang,Kara A. Moser,Ankit Dwivedi,Cornelus C. Hermsen,Belén Jiménez-Díaz,Sara Viera,Jorge M. Santos,Jorge M. Santos,Inês S. Albuquerque,Sangeeta N. Bhatia,John Bial,Iñigo Angulo-Barturen,Joana C. Silva,Geert Leroux-Roels,Chris J. Janse,Shahid M. Khan,Maria M. Mota,Robert W. Sauerwein,Miguel Prudêncio +26 more
TL;DR: A novel WSp malaria vaccine that employs transgenic sporozoites of rodent P. berghei parasites as cross-species immunizing agents and as platforms for expression and delivery of PfCS (PbVac), which is safe and induces functional immune responses in preclinical studies, warranting clinical testing and development.